Diabetology & Metabolic SyndromeSystems BiologyPeer-reviewed journal article
A multi-scale digital twin for adiposity-driven insulin resistance in humans: diet and drug effects
Tilda HerrgårdhiD, Christian SimonssoniD, Mattias EkstedtiD, Peter LundbergiD, Karin G. StenkulaiD, Elin NymaniD, Peter GennemarkiD, Gunnar CedersundiD
Abstract
AimsThe increased prevalence of insulin resistance is one of the major health risks in society today. Insulin resistance involves both short-term dynamics, such as altered meal responses, and long-term dynamics, such as development of type 2 diabetes. Insulin resistance also occurs on different physiological levels, ranging from disease phenotypes to organ-organ communication and intracellular signaling. To better understand the progression of insulin resistance, an analysis method is needed that can combine different timescales and physiological levels. One such method is digital twins, consisting of combined mechanistic multi-scale and multi-level mathematical models. We have previously developed a multi-level model for short-term glucose homeostasis and intracellular insulin signaling, and there exists long-term weight regulation models. However, no one has combined these kinds of models into an interconnected, multi-level and multi-timescale digital twin model. Herein, we present a first such multi-scale digital twin for the progression of insulin resistance in humans. MethodsThe model is based on ordinary differential equations representing biochemical and physiological processes, in which unknown parameters were fitted to data using a MATLAB toolbox. ResultsThe connected twin correctly predicts independent data from a weight increase study, both for weight-changes, for fasting plasma insulin and glucose levels, as well as for intracellular insulin signaling. Similarly, the model can predict independent weight-change data in a weight loss study, involving diet and the weight loss drug topiramate. These independent validation tests are confirmed by a chi-square test (() = 4.8 < 21 = 2, (12,0.05)). In both these cases, the model can also predict non-measured variables, such as activity of intracellular intermediaries, glucose tolerance responses, and organ fluxes. ConclusionsWe present a first multi-level and multi-timescale model, describing dynamics on the whole-body, organ and cellular levels, ranging from minutes to years. This model constitutes the basis for a new digital twin technology, which in the future could potentially be used to aid medical pedagogics and increase motivation and compliance and thus aid in prevention and treatment of insulin resistance.
- Citations
- 25
- FWCI
- 5.12
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A multi-scale in silico mouse model for insulin resistance and humanoid type 2 diabetes
Christian Simonsson, William Lövfors, … Gunnar Cedersund·bioRxiv·May 19, 2021
- Digital twin predicting diet response before and after long-term fasting
Oscar Silfvergren, Christian Simonsson, … Gunnar Cedersund·PLoS Computational BiologyPeer-reviewed·Sep 12, 2022
- A Microphysiological Model of Progressive Human Hepatic Insulin Resistance
Dominick J. Hellen, Jessica L. Ungerleider, … Linda Gay Griffith·Communications BiologyPeer-reviewed·Jan 14, 2026
- A Comprehensive Model of Glucose-Insulin Regulation Including Acute and Prolonged Effects of Physical Activity in Type 1 Diabetes
J. Deichmann, S. Bachmann, … H.-M. Kaltenbach·bioRxiv·Jun 9, 2021
- Mathematical diabetes disease progression modeling in the integrated glucose-insulin model among individuals with impaired glucose tolerance from the Finnish Diabetes Prevention Study
SM Sheikh Ghadzi, Mats O. Karlsson, … Finnish Diabetes Prevention Study Group·bioRxiv·Mar 3, 2026
- Modeling physiological insulin sensitivity and pre-diabetic insulin resistance in multiple hPSC-derived cell types
Max Friesen, Rudolf Jaenisch·Signal Transduction and Targeted TherapyPeer-reviewed·Jul 21, 2026